Impella, build it and the evidence will come…?
By Dr Jonathan ShurlockEdited by Dr Nitin Chandra Mohan The results of the DanGer Shock trial were recently presented at the American College of Cardiology…
View More Impella, build it and the evidence will come…?
There is benefit to communicating CVD risk with patients: A meta-analysis
By Dr Jonathan Shurlock Edited by Dr. Ahmed El-Medany A meta-analysis from Dr Mina Bakhit (@Mina_Bakhit) and colleagues has explored the role of cardiovascular disease (CVD)…
View More There is benefit to communicating CVD risk with patients: A meta-analysis
Patients with heart failure: Virtual wards
By Dr Jonathan Shurlock Edited by Dr. Ahmed El-Medany NHS England have published data related to ‘virtual wards’, which since October have been a recommended option…
View More Patients with heart failure: Virtual wards
Cardiac waiting lists: An outlier or some progress? Part V
By Dr Jonathan Shurlock Edited by Dr. Ahmed El-Medany Each of our previous reports have described the continued growth of cardiac waiting lists, including when we…
View More Cardiac waiting lists: An outlier or some progress? Part V
Apixaban reduces the risk of stroke in device-detected subclinical atrial fibrillation
By Dr. Florence Mouy Edited by Dr. Ahmed El-Medany The ARTESIA trial (Apixaban for the Reduction of Thrombo-Embolism in Patients with Device-Detected Sub-Clinical Atrial Fibrillation) has…
View More Apixaban reduces the risk of stroke in device-detected subclinical atrial fibrillation
The diagnostic yield of NT-proBNP in a regional heart failure pathway
By Dr. Jonathan ShurlockEdited by Dr. Ahmed El-Medany An interesting study in BMJ Open Heart has explored the diagnostic yield of a regional heart failure referral pathway…
View More The diagnostic yield of NT-proBNP in a regional heart failure pathway
Do patients with minimally symptomatic severe aortic stenosis benefit from TAVI?
By Dr. Florence Mouy Edited by Dr. Ahmed El-Medany A study by Huded et al has assessed the outcomes of transcatheter aortic valve implantation (TAVI) in…
View More Do patients with minimally symptomatic severe aortic stenosis benefit from TAVI?
Cardiac waiting lists continue to grow: Part IV
By Dr. Jonathan ShurlockEdited by Dr Saadia Aslamy NHS England have released the latest waiting list figures, for the end of August. These have highlighted a further…
View More Cardiac waiting lists continue to grow: Part IV
Bumetanide shortage: important consideration for community heart failure teams
By Dr. Jonathan Shurlock The Department for Health and Social Care (DHSC) has issued a medicine supply shortage notification for Bumetanide oral tablet preparations (1mg and…
View More Bumetanide shortage: important consideration for community heart failure teams
Decreasing access to ALS training: unknown impact on outcomes
By Dr. Jonathan ShurlockEdited by Dr Saadia Aslamy A recently published article in the BMJ laments the removal of Advanced Life Support training at both undergraduate and…
View More Decreasing access to ALS training: unknown impact on outcomes